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Abstract
Background: Transgenic mouse models are increasingly used to study the pathophysiology of human
cardiovascular diseases. The aortic pulse wave velocity (PWV) is an indirect measure for vascular stiffness and a
marker for cardiovascular risk.
Results: This study presents a cardiovascular magnetic resonance (CMR) transit time (TT) method that allows the
determination of the PWV in the descending murine aorta by analyzing blood flow waveforms. Systolic flow pulses
were recorded with a temporal resolution of 1 ms applying phase velocity encoding. In a first step, the CMR
method was validated by pressure waveform measurements on a pulsatile elastic vessel phantom. In a second
step, the CMR method was applied to measure PWVs in a group of five eight-month-old apolipoprotein E deficient
(ApoE(-/-)) mice and an age matched group of four C57Bl/6J mice. The ApoE(-/-) group had a higher mean PWV
(PWV = 3.0 ± 0.6 m/s) than the C57Bl/6J group (PWV = 2.4 ± 0.4 m/s). The difference was statistically significant
(p = 0.014).
Conclusions: The findings of this study demonstrate that high field CMR is applicable to non-invasively determine
and distinguish PWVs in the arterial system of healthy and diseased groups of mice.
Background
Cardiovascular diseases are among the most common
causes of death in industrialized countries. Risk factors
include increased age, male sex, diabetes, hypertension,
and lipoprotein abnormalities. The aorta provides at
least 60 to 70% of systemic compliance [1]. Reduced
elasticity and compliance of the aorta are etiologic in
cardiovascular diseases such as atherosclerosis and
therefore serve as early indicators of asymptomatic
atherosclerotic lesions [2,3]. The velocity of pressure
and flow pulses travelling down an elastic vessel termed
the pulse wave velocity (PWV) increases with arterial
stiffness [4]. The PWV is a direct measure of arterial
stiffness [3] and serves as an independent predictor for
cardiovascular risk and mortality [5-8] in many cases of
CVD, including atherosclerosis [9]. In this study, a high
field cardiovascular magnetic resonance (CMR) protocol
using the transit time (TT) method [10] was developed
and tested for its capability to distinguish groups of
healthy and atherosclerotic mice by means of the PWVs
in the descending aortas.
Originally, the transit time method has been used to
determine the PWV in humans using several invasive
methods [11,12] and non-invasive methods such as
ultrasound [13,14] and CMR [15] before it was applied
to smaller mammals such as mice. To this day new
CMR methods have been refined by many workgroups
[16,17] and they constitute a comprehensive technique
for the characterization of morphologic and functional
arterial systemic parameters in humans.
In the past, the need to determine morphologic and
functional parameters of the murine arterial system arose.
Genetically engineered phenotypes of mice that are defi-
cient in apolipoprotein E (ApoE(-/-) mice) spontaneously
develop severe hyperlipidemia and atherosclerotic lesions
at the arterial wall [18]. ApoE(-/-) mice develop all stages of
lesions observed during atherogenesis that resemble
lesions found in humans [19]. Therefore and for its short
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generation times, the ApoE(-/-) mouse model became an
important model for human atherosclerosis [20].
Physical dimensions in mice are approximately 20
times smaller than in humans. With isoflurane anesthe-
tized mice have high heart rates of 8 to 10 beats per
second, whereas healthy humans at rest have heart rates
of 0.8 to 1.7 beats per second. The necessities of very
high spatial and temporal resolutions constitute the
challenges for the determination of the PWV. In CMR
of the corresponding animal model, the acquirable spa-
tial resolution is limited by the signal-to-noise ratio
(SNR). In the past, CMR systems did not provide a suffi-
cient SNR to allow for accurate PWV measurements in
mice. New high-field CMR systems facilitate a very high
SNR and allow for examinations of morphologic and
also functional parameters of the arterial system of mice
[21,22].
Alternatively to CMR, ultrasound methods have been
utilized to non-invasively measure PWVs in mice
[23-25]. However, these ultrasound methods turned out
to be highly observer dependent and in general were
limited by acoustical windows in the thorax and by
angular offsets in the alignment of the ultrasound trans-
ducer and the aorta [26]. The limited spatial resolution
of ultrasound is a substantial impediment for morpholo-
gical studies [27].
The primary objective of this study was to test the
applicability of CMR and the TT method to assess the
regional PWV of the descending murine aorta. The MR
measurements were performed on a CMR system with a
main magnetic field of 17.6 T. The accuracy and repro-
ducibility of the CMR method were validated on a vessel
phantom made of poly(vinyl alcohol) cryogel (PVA-C).
In addition, it was tested whether the precision of the
CMR method is sufficient to differentiate the mean
PWVs of groups of atherosclerotic ApoE(-/-) and healthy
wild type mice.
Methods
The Transit Time Method
During each systole the left ventricle of the heart ejects
one stroke volume of blood into the aortic root, hence,
generating a pulse beat. The pulse beat that in fact is a
local increase of blood pressure and flow velocity propa-
gates down the aorta with a velocity that is named the
pulse wave velocity (PWV).
The principle to measure arterial PWV with the TT
method is as follows. At least two measurement sites, I
and II in Figure 1a, are to be selected on the aorta at a
mutual distance, Δz. The transit time, Δt, which the
pulse needs to travel from location I to II is to be mea-
sured (see Figure 1b). The PWV is calculated as PWV =
Δz/Δt. This procedure is called the two-point TT
method.
The generalization of the two-point TT method is the
multi-point TT method [28-30]. It measures the transit
times of the pulse waves in multiple locations along the
path of wave propagation. The PWV is the constant of
proportionality between the distances and the corre-
sponding transit times.
Figure 1b and 2a reveal that flow and pressure pulse
curves show a gradual rather than an instantaneous
increase. However, a distinctive feature, the foot of the
pulse wave, is necessary to determine the transit time.
The foot of the pulse wave is defined as the intersection
point of a regression line fitted to the velocity or
Figure 1 In vivo PWV measurements in the descending murine aorta. Figure 1a shows a reference scan of the murine aorta and the
positioning of velocity measurement slices (I: thoracic aorta, II: abdominal aorta). Arrows indicate the regions of velocity measurements (two-
point TT method). Figure 1b depicts representative flow velocity waveforms of an ApoE(-/-) mouse and the regression lines that determine the
pulse onset time. Only the late diastole and the early systole were recorded. This particular measurement yields a PWV = Δz/Δt = 2.6 m/s.
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pressure values before the pulse and another line fitted
to the early increasing values.
Phantom Experiments
The accuracy of the MR method was tested on an elas-
tic vessel phantom that was connected to a custom built
flow and pressure pulse generator. The phantom
allowed for the determination of PWVs by CMR mea-
surements of flow waveforms and for reference mea-
surements of pressure waveforms utilizing a pressure
catheter that was inserted in the outlet end of the vessel
(Figure 3). The PWVs obtained by the two different
measurement methods were compared to each other in
order to give evidence of the accuracy and precision of
the MR method.
The phantom material had to have appropriate physi-
cal properties, e.g., mechanical strength, uniformity,
long-term stability, and a modulus of elasticity resem-
bling animal tissue. Poly(vinyl alcohol) cryogel (PVA-C),
discovered independently by Peppas et al. and Nambu et
al. [31,32], has high breaking strengths and physiologic
elastic moduli ranging from 0.1 to 1.0 MPa [33] and
was, therefore, used to build the phantom vessel. Aqu-
eous poly(vinyl alcohol) solution (15% w/w) was injected
into an acrylic mold and crosslinked to form the gel by
repeated freezing and thawing. The elastic modulus of
the gel depends amongst others on the number of the
freeze-thaw cycles, on the concentration of the aqueous
solution, and essentially on the thaw rate [33,34].
The vessel phantom had an inner diameter of 6 mm
and a wall thickness of 0.25 mm. Its length was
approximately 8 cm. The vessel was dimensioned
according to Eq.[1], the Moens-Korteweg equation [35],
to have a PWV in the physiological range of 2.0 to 6.5
m/s.
PWV
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d
=  (1)
E is Young’s modulus of elasticity, h and d are the
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Figure 2 Pressure wave measurements on the vessel phantom. Figure 2a shows a representative time course of the pressure wave recoded
on the vessel phantom (sample rate = 100 ms-1). Figure 2b illustrates the transit of the pressure wave. In order to depict the PWV as the slope
of the linear regression line, the independent variable, i.e., the pulse onset time is exceptionally plotted along the abscissa. The diagram shows
one of six series of measurements that were performed at different installation heights (here +2 mm) of the vessel phantom relative to the MR
iso-center.
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Figure 3 Simplified scheme and photograph of the pulsatile
elastic vessel phantom. The phantom was used to investigate the
accuracy and the precision of the developed MR TT method.
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density. The phantom was stored in a water bath to sta-
bilize for at least 14 days prior to measurements because
PVA-C is subject to an aging process that can affect its
elasticity [34].
A homemade pressure and flow pulse generator was
connected to the inlet end of the vessel phantom. A
function generator (F34, Interstate Electronics Corpora-
tion, Anaheim, CA, USA) controlled the pulse generator.
The function generator was set to generate pressure
pulses every 1.8 s. Therewith, residual waves reflected at
impedance mismatches inside the vessel phantom setup
could decay completely between pulses. The function
generator also triggered the data acquisitions of the MR
system and of the setup used to record the pressure
waves inside the vessel phantom.
The setup to record pressure waves comprised a pres-
sure catheter, a signal amplifier, and a storage oscillo-
scope. The catheter was compounded of a blunted
canula (TSK-Supra, Ebhardt-Söhne GmbH, Geislingen,
Germany) and a Statham P23XL pressure transducer
(Viggo-Spectramed, Inc., Oxnard, CA, USA). The signal
amplifier was an MBS STAT ZAK (ZAK Psychologische
und Physiologische Instrumente GmbH, Simbach, Ger-
many). The storage oscilloscope was a TDS 3032 (Tek-
tronix Inc., Beaverton, OR, USA).
The outlet end of the vessel was connected to a reser-
voir filled with an aqueous solution of 1.75 mM CuSO4.
The height of the reservoir was adjusted in order that
the vessel did not bloat or collapse. Two plastic rods
supported the vessel on one side to prevent it from
swinging in the transversal direction but allowed it to
expand during the transit of the pulse.
The multi-point TT method was used to determine
the PWV of the vessel phantom by pressure measure-
ments. The measurement positions of the pressure
catheter were determined at its protruding end with a
calliper gauge. The pressure data were analyzed in
MATLAB (The Mathworks, Inc., Natick, MA, USA) to
determine the onset times of the pressure waves for
each measurement position of the pressure catheter.
The measurement positions were plotted versus the cor-
responding pressure pulse onset times. The slope of the
linear regression yielded the PWV (see Figure 2b). The
multi-point TT measurements were performed at six
different installation heights of the vessel phantom that
ranged from -13 mm to 12 mm from the MR iso-center.
The PWV at the MR iso-center was determined by lin-
ear regression through the PWV and installation height
values.
The MR system that was used for the phantom and in
vivo measurements was a Bruker AVANCE 750 spectro-
meter (Bruker Biospin, Rheinstetten, Germany) with a
vertical main magnetic field of 17.6 T and a bore size of
89 mm. The self-shielded gradient insert, a Bruker
Micro 2.5, had a maximum gradient strength of 993
mT/m and an inner diameter of 40 mm. The homebuilt
transversal electromagnetic mode radio frequency (RF)
resonator had an accessible inner diameter of 25 mm.
The MR sequence applied phase velocity encoding to
record the time courses of the flow velocities. The
sequence was based on a two-dimensional FLASH
sequence with incorporated velocity compensating gra-
dients in all three gradient directions (Figure 4). To
encode through-slice flow velocities, bipolar velocity
encoding gradients were superposed onto the velocity
compensating gradients in the slice direction. Three
flow encoding steps were applied to each scan. The
velocity-encoding window of the MR sequence was set
to ± 0.20 m/s to accommodate the maximal flow veloci-
ties. The flow encoding gradients required the maximal
available gradient power.
Transit times of the pulse waves are in the range of a
few milliseconds, therefore, a temporal resolution of 1
ms was necessary to be able to obtain the PWV from
the time courses of arterial blood flow velocities. The
intrinsic temporal resolution of the MR sequence,
equivalent to its repetition time, was 5 ms. Hence the
time courses of the flow velocities had to be sampled in
RF pulse echo
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phase encoding
gradient
slice select & 
flow encoding
gradient
heart trigger VD
FE = flow encoding
VD = {0ms; 1ms; 2ms; 3ms; 4ms}; VD incremented after each call
frames loop:           8 x 5 ms
movie segment loop: 5 x (VD + 40 ms)
slice loop:            2 times
phase encoding loop:        150 times
flow encoding loop:            3 times
FE FE
Figure 4 Scheme of the flow encoding MR method used to
measure the PWV in the descending murine aorta. A fivefold
repetition of the frames loop with interjacent incrementation of the
variable delay produced an effective temporal resolution of 1000
time frames per second.
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an interleaved fashion. The sequence was initiated five
times, every time with an additional delay of 1 ms
between the trigger signal and the initiation of the
sequence. The resulting five data streams were inter-
leaved in the post processing to generate a recording of
flow velocities with a temporal resolution of 1 ms. The
detailed timing and loop structure of the MR sequence
are visualized in Figure 4.
The spatial in-plane resolution was 147 × 147 μm2
and the slice thickness was 1 mm. The field of view
(FOV) was 22 × 22 mm2. The echo time was 1.6 ms.
The Gauss RF excitation pulse had a length of 200 μs
and an excitation angle of 20°. Signal averaging was not
applied.
The two-point and multi-point TT methods were used
to determine the PWV of the vessel phantom by MR
measurements. A set of two-dimensional Fast Low
Angle Shot (FLASH) experiments was leading the mea-
surement protocol to localize the measurement posi-
tions on the vessel phantom. The MR imaging slices
were positioned perpendicularly to the vessel at posi-
tions ±2.5 mm, ± 5.0 mm, ± 7.5 mm, and ± 10.0 mm
from the magnets iso-center. A perpendicular slice
orientation was crucial to avoid displacement artifacts
caused by fluid flowing out of the imaging slice.
MR data were processed with a custom written rou-
tine using MATLAB. Velocity information was com-
puted for pixels inside the vessel lumen by fitting a line
to the phase values as a function of the first moments
of the velocity encoding gradients (phase difference
method). For every time frame the velocities were aver-
aged over the luminal area.
64 pressure measurements were performed before 80
MR measurements. Differences in the mean PWV values
obtained on the vessel phantom by the two measure-
ment methods were tested by a two-sided t-test for
unpaired data points for the hypothesis of equality
against the alternative of differing values. The data
points were not paired because many parameters, such
as static pressure, temperature, and acoustic noise could
not be held constant during the transition from pressure
to MR measurements due to limited access and the
strong magnetic field inside the magnet. The hypothesis
was accepted for p-values ≥ 0.05. PWV values are given
as mean ± standard error (SE).
In Vivo Experiments
The proposed MR method was designed to utilize the
two-point TT method in vivo in the descending murine
aorta. Nine MR measurements were performed on a
group of five female eight-month-old ApoE(-/-) mice and
eight measurements on a group of four age- and sex-
matched C57Bl/6J mice. The ApoE(-/-) mice were fed a
western type diet (TD 88137, Harlan Laboratories, Inc.,
Indianapolis, IN, USA) 10 weeks prior to MR measure-
ments. During the MR examinations, the mice were
anesthetized with an isoflurane inhalation (1.5 - 2.0 Vol.
%) in O2 (2 L/min) applied by means of a nose cone.
Mice were placed vertically (head up) in the RF resona-
tor. Due to the small diameters of the gradient insert
and the RF resonator, their body temperature could be
kept constant at 37°C by adjusting the temperature of
the gradient insert temperature control unit.
A pressure sensitive pneumatic balloon (Graseby Med-
ical Limited, Watford, United Kingdom) was placed
between the inner RF resonator wall and thoraces of
mice to detect cardiac trigger and respiratory gating sig-
nals. Outside of the gradient insert, a pressure transdu-
cer (24PCEFA6 D, Honeywell S&C, Golden Valley, MN,
USA) transformed the pressure signal from the balloon
into an electrical signal that was amplified and pro-
cessed in real-time by a homebuilt unit. Thus, electrical
interference between the trigger signal and gradient
fields oscillating in the same frequency domain was
avoided.
All experimental procedures were in accordance with
institutional and internationally recognized guidelines
and were approved by the Regierung von Unterfranken
(Government of Lower Franconia, Germany). The refer-
ence number of the permit of the animal experiments is
55.2-2531.01-19/07.
Two imaging slices were positioned perpendicularly to
the thoracic and the abdominal aorta (as illustrated in
Figure 1a). Reasonable in vivo experiment times only
allowed for the two-point TT method to be applied.
Slice separations were maximized in order to minimize
the errors in the measured PWVs. Again, a perpendicu-
lar slice orientation was of crucial importance. To loca-
lize the descending aorta, a set of two-dimensional
FLASH experiments was leading the measurement
protocol.
The velocity-encoding window was set to ± 1.66 m/s
to accommodate the maximal blood flow velocities. The
RF excitation pulse had an excitation angle of 40°. The
mice had a heart period of approximately 115 ms. A
time window of 40 ms was sufficient to sample the late
diastole and early systole. All other parameters of the
measurement protocol were set as in the measurements
on the vessel phantom. The total image acquisition
times ranged from 15 to 20 min.
MR data were processed using the MATLAB routine
that was also used for the analysis of the data acquired
on the vessel phantom. The curve progression in the
velocity-time diagrams showed sharp bends between the
sections before and during the pulse. This allowed for a
semi automatic selection of the fit ranges that defined
the onset times of the flow pulse. The fit range before
the pulse was selected manually. It included data points
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on an approximate horizontal line. The beginning of the
pulse fit region was set automatically as a series of three
consecutive data points with velocity values at least two
standard deviations above the extrapolated fit line of the
section before the pulse. The end point was selected
manually as the last data point on the first straight por-
tion of the flow pulse section. The program AMIRA
(Visage Imaging, Inc., San Diego, CA, USA) was applied
to gauge the distance between the two measurement
locations. Therefore, straight-line segments were drawn
along the luminal midline in a longitudinal reference
scan of the aorta.
Isoflurane causes respiratory depression and, therefore,
anesthetized mice develop a gasping breathing pattern
with a period of approximately 1 s to 1.5 s. The dura-
tion of each respiratory movement is approximately 0.4
s. The MR data were acquired in the intermediate
movement-free time intervals. From the periodicity of
previous respirations, the homebuilt heart-triggering/
breath-gating unit anticipates the next phase of respira-
tory motion and stops the MR data acquisition before
the respiratory motion sets in. Data acquisition is con-
tinued approximately 0.4 s after the detected onset of
breathing motion. Occasionally, the breathing pattern
was not precisely periodic. Then data was acquired dur-
ing the respiratory movement and motional artifacts in
the MR images were the result. Sporadic non-periodic
respiration was observed during all measurements, but
showed no adverse motional artifacts in most of the
measurements. In some of the motional artifacts, the
signal amplitude and phase information of extra-luminal
pixels were shifted into the vessel lumen. Those pixels
were excluded from the calculation of the flow velocities
when the anatomical structures that those pixels
belonged to could be identified visually.
Differences in the mean PWV values of the two ani-
mal groups were tested by a two sided t-test for the
hypothesis of equality against the alternative of a higher
value for the ApoE(-/-) group. The hypothesis was
rejected in favor of the alternative for p-values < 0.05.
In this work all in vivo PWV values are given as mean ±
standard deviation (SD).
Results
Phantom Experiments
On the vessel phantom, a reference PWV = 3.31 ± 0.18
m/s was obtained by the pressure catheter measure-
ments. The multi-point MR measurements determined a
PWV = 3.32 ± 0.18 m/s. The PWV values of the pres-
sure and MR measurements are not different with statis-
tical significance (p = 0.999). The parameters and results
of the validation measurements are summarized in
Table 1. The PWV values of the two-point MR mea-
surements agree within their standard errors. A
representative pressure wave in the vessel phantom and
the multi-point TT method (explained in the method
section) are shown in Figure 2.
In Vivo Experiments
Figure 1 shows representative time courses of flow veloci-
ties, which were recorded on an ApoE(-/-) mouse. The
measured PWV values (Figure 5) ranged from 1.9 m/s in
a C57Bl/6J mouse to 3.8 m/s in an ApoE(-/-) mouse. The
average values of each animal group are PWV = 3.0 ± 0.6
m/s for ApoE(-/-) mice and PWV = 2.4 ± 0.4 m/s for
C57Bl/6J mice. The mean value of the ApoE(-/-) group
was higher than that of the C57Bl/6J group with statisti-
cal significance (p = 0.014). The change of the heart peri-
ods of examined mice was smaller than 5 ms during
experiments. The experiment parameters and the results
for both animal groups are summarized in Table 2.
Discussion
A pulsatile elastic vessel phantom with a physiological
PWV was developed. PWV values of the vessel phantom
were investigated by MR and pressure measurements.
The mean PWV determined by the MR multi-point TT
method showed no statistically significant difference to
the reference value. The developed MR TT method is
accurate. The agreement of the MR two-point TT mea-
surements at the different measurement positions on
the vessel phantom indicates that the MR method deli-
vers reproducible PWV values. These measurements
also indicate that the separation of the imaging slices
shall be maximized in order to reduce the uncertainty in
the measured PWV. A statement about the in vivo pre-
cision of the MR method in a best-case scenario cannot
be made from the results of the phantom measure-
ments, because the standard deviation of the phantom
measurements is higher than that of the in vivo mea-
surements. Different error mechanisms, such as residual
transversal vessel wall oscillations [36], water droplets
Table 1 Parameters and results of the validation PWV
measurements
pressure TT measurements
number of data points measurement positions PWV
64 multi-point 3.31 ± 0.18 m/s*
flow velocity TT method
number of data points measurement positions PWV
80 multi-point 3.32 ± 0.18 m/s*
20 two-point at ± 10.0 mm 3.30 ± 0.20 m/s
20 two-point at ± 7.5 mm 3.39 ± 0.49 m/s
20 two-point at ± 5.0 mm 3.17 ± 0.29 m/s
20 two-point at ± 2.5 mm 3.44 ± 0.94 m/s
PWV values are given as mean ± standard error. *The mean values of the
pressure and MR measurements do not show a statistically significant
difference (p = 0.99).
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forming on the outside of the phantom vessel wall, and
a jitter in the pressure pulses reduced the precision of
the phantom measurements.
The results of this study show that the PWV is mea-
surable in vivo in the descending murine aorta using a
two-point TT CMR method and an CMR system with a
main magnetic field strength of 17.6 T. The measure-
ments are made possible by the high SNR intrinsic to
high-field CMR and the large filling factor of the used
RF resonator. The interleaved acquisition scheme and
the pneumatic triggering technique (explained in the
methods section) provide the necessary temporal resolu-
tion. Heart periods are sufficiently stable throughout the
experiments, due to reliable anaesthesia and body tem-
perature control. Flow compensation and the short echo
time of the MR sequence greatly reduce motional
artifacts. Additionally, the short echo time alleviates sus-
ceptibility artifacts, which are usually caused by bound-
aries of tissues with differing magnetic susceptibilities in
high-field CMR.
Wave reflections, mainly generated by the micro-vas-
cular bed, i.e. the arterioles, will change the shape of the
flow wave and will affect the estimation of PWVs
[37,38]. It is critical for the determination of the PWV
of the forward travelling pulse wave that only the reflec-
tion-free part of the wave is analyzed. Assuming a
hypothetical PWV of 5 m/s and a distance of 20 mm
between the abdominal measurement position and the
microvascular bed, the reflected pulse wave needs 8 ms
to return to the abdominal aorta. In this study, at most
the early 7 ms of the flow velocity upstroke were used
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Figure 5 PWV values in descending murine aortas. Figure 5a shows the individually measured PWVs of ApoE(-/-) and C57Bl/6J mice plotted
versus the body masses. Vertically aligned datapoints belong to the same animal. Figure 5b shows a box-and-whiskers plot of the PWV values of
the groups of eight-month-old female ApoE(-/-) and C57Bl/6J mice. The whiskers indicate the minimum and maximum values in each animal
group. The boxes indicate the lower and upper quartiles; the band near the middle of each box represents the median. The ApoE(-/-) mice
received a western type diet 10 weeks prior to the measurements. The PWV values are stated as mean ± standard deviation. The number of
measurements on each group is indicated by n.
Table 2 Parameters and results of the in vivo MR PWV measurements
parameter (mean ± standard deviation) ApoE (-/-)group C57Bl/6J group
age of animals (mo.) 8 8
number of animals 5 4
number of measurements 9 8
body mass (g) 28.4 ± 4.5 30.4 ±0.9
anesthetic
isofluorane (%) 1.8 ± 0.2 1.7 ± 0.2
in O2 (l/min) 1.5 ± 0.0 1.8 ± 0.4
avg. heart period (ms) 109 ± 9 112 ± 4
change in heart period of single experiments (ms) 2.0 ± 1.6 2.2 ± 1.5
distance between measurement locations (mm) 12.2 ± 1.1 9.5 ± 1.4
transit time between measurement locations (mm) 4.1 ± 0.9 4.2 ± 1.1
PWV* (m/s) 3.0 ± 0.6 2.4 ± 0.4
*The mean PWV of the ApoE(-/-) group is higher than the mean PWV of the C57Bl/6J group with statistical significance (p = 0.014).
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for the calculation of the PWV, therewith, wave reflec-
tions did not impose an impediment.
The PWV measured on the group of eight-month-old
ApoE(-/-) mice was 25% higher than the PWV in the age-
matched wild-type group. The in vivo experiments
showed, that the precision of the measurement method
suffices to distinguish between the PWVs of different ani-
mal groups. The difference is statistically significant (p =
0.014). The PWV values measured in mice in this study
are lower than values previously stated in literature but
agree in general with most publications [25,39,40]. The
deviations between the findings of this study and litera-
ture might be caused by systematic deviations inherent to
the different methods of measurement, as the different
results of ultrasound and pressure measurements on
alike animal groups by Hartley and Wang suggest. Devia-
tions to the findings can also be caused by the differences
in age of the animals, because different animal strains
were used, or because the animals were positioned verti-
cally in the MR system. The PWVs measured in vivo in
this study highly deviate from values found in an MR
study that analyzed the part of the pulse wave that con-
tains wave reflections [38].
Wang et al. found no significant differences in PWV
values between ApoE(-/-) and C57Bl/6J mice that were
younger than 13 months [24]. In this study, a significant
difference was observed at eight months of age already. In
the current work, ApoE(-/-) mice received a different, a wes-
tern type diet, which accelerates aortic wall remodelling
and increases elastic destruction and thus the PWV [41].
To make a general remark about the field of applica-
tion of the TT method, it has to be considered that the
TT method delivers a regional PWV value, which is
averaged over the propagation pathway in between the
measurement locations. In early stages of atherosclerosis
diminutive vascular lesions are scattered along the aorta,
which affect the PWV locally. Therefore, interest of
research is also on the local elastic properties of the
murine aorta. Our workgroup successfully applied the
QA method [17] to mice in another study [22] to deter-
mine local PWVs. The QA method uses the volume
flow (Q) to cross-sectional area (A) relation during the
early systole to calculate the PWV. The QA method is
unrivalled in local estimation of the PWV. But since it
employs cross-sectional vessel areas, it comprises an
additional source of error. The TT method is more
robust and requires less user interpretation because it
operates without the determination of cross-sectional
areas [42].
Conclusions
This study demonstrates the feasibility of the non-inva-
sive determination of the pulse wave velocity by the
transit time method and high-field CMR. The measured
PWVs are accurate and reproducible in comparison to
reference pressure measurements on a vessel phantom
and sufficiently precise to distinguish between animal
groups. Therefore, the measured PWV can be used as a
marker to classify the state of arterial dysfunction in liv-
ing mice. Due to the short in vivo acquisition times of
15 to 20 minutes, the presented MR method is applic-
able to enhance studies of morphologic parameters
characterizing the murine arterial system [21,43] by add-
ing the PWV as a functional parameter to form a com-
prehensive set of parameters.
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